<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01335386</url>
  </required_header>
  <id_info>
    <org_study_id>FECN2006KLY-01</org_study_id>
    <nct_id>NCT01335386</nct_id>
  </id_info>
  <brief_title>Investigation of KLYX in Patients With Constipation</brief_title>
  <official_title>Efficacy and Safety of KLYX Versus Glycerine Enema in Chinese Patients With Constipation - a Randomised, Assessor-blind Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ferring Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomised, assessor-blind, multi-centre pilot study to investigate the comparative
      safety and efficacy of KLYX and glycerine enema in the symptomatic treatment of constipation
      in Chinese patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall efficacy of enema</measure>
    <time_frame>immediately following enema administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first bowel movement</measure>
    <time_frame>Immediately following enema administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's overall satisfaction with enema treatment</measure>
    <time_frame>Immediately following enema administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool form after enema treatment</measure>
    <time_frame>Immediately following enema administration</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>KLYX</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Glycerine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>KLYX</intervention_name>
    <arm_group_label>KLYX</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glycerine</intervention_name>
    <arm_group_label>Glycerine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have signed the informed consent form and have been verbally explained the details of
             the trial and treatment procedures

          -  Ethnically Chinese

          -  Males or females aged between 18 and 65 years inclusive

          -  A history of constipation symptoms for at least 6 months fulfilling, with occurrence
             of two or more of the following symptoms during the 3 months before screening (the 3
             months need not be consecutive):

             i. Very hard (pellet-like) and/or hard stools (Type 1 or 2 of the Bristol Stool Scale)
             for at least 25% of the time; or ii. Sensation of incomplete evacuation at least 25%
             of the time; or iii. Straining during defecation at least 25% of the time; or iv.
             Sensation of anorectal obstruction or blockage often during defecation at least 25% of
             the time; or v. Manual manoeuvres needed often to facilitate defecations (e.g. digital
             evacuation, support of the pelvic floor) at least 25% of the time; or vi. Fewer than 3
             defecations per week.

          -  Patient has had no bowel movement (i.e. still constipated) two days prior
             randomisation.

        Exclusion Criteria:

          -  Any disorder or laboratory result at Screening that in the judgement of the
             investigator that will place the subject at excessive risk if participating in a
             controlled study

          -  Clinically suspected to have colorectal cancer

          -  Significant gastroparesis or gastric outlet obstruction

          -  Hypersensitivity to sodium docusate and/or sorbitol

          -  Hypersensitivity to glycerine

          -  Pregnant or lactating women, women who intend to conceive, or women who are sexually
             active and capable of pregnancy who are not using a method of birth control (e.g.
             prescription hormonal contraceptives, intrauterine device, double-barrier method, male
             partner sterilization)

          -  Diabetic patients currently on insulin therapy

          -  Having participated in other clinical trial(s) within the 3 (three) months prior
             screening

          -  Unable to withdraw medications that may affect gastrointestinal motility such as
             prokinetics, erythromycin analogues, laxatives, etc.

          -  Unable to meet or perform study requirements: known or suspected inability to comply
             with the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Development Support</last_name>
    <role>Study Director</role>
    <affiliation>Ferring Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Changhai Hospital, The Second Military Medical University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renji Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2011</study_first_submitted>
  <study_first_submitted_qc>April 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2011</study_first_posted>
  <last_update_submitted>February 3, 2012</last_update_submitted>
  <last_update_submitted_qc>February 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

